Piperacillin Sodium Tazobactam Sodium, the full name of Piperacillin Sodium Tazobactam Sodium for Injection, has antimicrobial properties and is mainly used for the treatment of moderate to severe infections caused by β-lactamase-producing bacteria susceptible to piperacillin tazobactam. This drug is a combination preparation in which piperacillin sodium exerts its bactericidal action by inhibiting bacterial septum formation and cell wall synthesis, and exhibits antimicrobial activity in vitro against many Gram-positive and negative aerobic and anaerobic bacteria. Tazobactam sodium has little or no clinical antimicrobial activity in vitro, but inhibits beta-lactamase enzymes of molecular classification A. The most common adverse reaction to piperacillin sodium tazobactam sodium for injection is diarrhea, and other common adverse reactions include rash, pruritus, nausea, vomiting, allergic reactions, injection local irritation or pain, phlebitis, thrombophlebitis, edema, thrombocytopenia, pancreatitis, fever, fever with eosinophilia, and elevated serum aminotransferase. In addition, allergy to penicillins, cephalosporin antibiotics or β-lactamase inhibitors is prohibited, and there is insufficient data on clinical use in pregnant and lactating women. If you need to use piperacillin sodium tazobactam sodium for injection, it is recommended to consult a professional doctor, follow the doctor’s instructions to standardize the treatment, you can not blindly use the drug at will.